Side-by-side comparison of AI visibility scores, market position, and capabilities
Banking infrastructure APIs with direct Federal Reserve and Visa connections for fintechs and neobanks; YC-backed offering ACH, RTP, and card issuance competing with Column and Unit in post-Synapse BaaS market.
Increase is a San Francisco-based banking infrastructure company providing direct-access banking APIs to technology companies — enabling fintechs, neobanks, payroll platforms, and embedded finance products to programmatically send and receive money through direct connections to the Federal Reserve (for same-day ACH and RTP), Visa (for card issuance), and other financial networks, without the intermediary bank complexity that most BaaS (Banking-as-a-Service) providers require. Founded in 2020 and a Y Combinator graduate, Increase serves technology companies across bill pay, payroll, digital wallets, embedded lending, and sponsor banking use cases.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.